Half Year 2021 Cosmo Pharmaceuticals NV Earnings Call Transcript
Ladies and gentlemen, welcome to the release of half year results 2021 conference call and live webcast. I'm Moira, the Chorus Call operator. (Operator Instructions) The conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Alessandro Della Cha, Executive Director and CEO. Please go ahead, sir.
Thank you very much. Welcome, everyone, to our half year report 2021 conference call. I hope the presentation is visible for you all.
Let's start with a quick introduction and a recap on where we stand. Currently, our half year is ending with EUR 28.4 million revenues, EUR 15.2 million of which is related to manufacturing of our own products and related services and EUR 5.8 million to the manufacturing of generic products and other related services. We have cash EUR 2.4 million of royalties and received
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
